Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The displayed values in the cca application for the extended brilliance workspace should be labeled as being the percentage of increase in the wall thickness between the end diastolic and the end systolic states but what is actually being displayed is the decrease in wall thickness from the end systolic to the end diastolic state.